Clinical Experience With Intravenous Zanamivir Under an Emergency Investigational New Drug Program in the United States

被引：13

作者：

Chan-Tack, Kirk M. ^{[1
]}

Gao, Arlene ^{[1
]}

Himaya, Amalia C. ^{[1
]}

Thompson, Elizabeth G. ^{[1
]}

Singer, Mary E. ^{[1
]}

Uyeki, Timothy M. ^{[2
]}

Birnkrant, Debra B. ^{[1
]}

机构：

[1] US FDA, Div Antiviral Prod, Ctr Drug Evaluat & Res, Silver Spring, MD USA

[2] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA

来源：

JOURNAL OF INFECTIOUS DISEASES | 2013年 / 207卷 / 01期

关键词：

CRITICALLY-ILL PATIENTS; 2009; H1N1; INFLUENZA;

D O I：

10.1093/infdis/jis637

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：196 / 198

页数：3

共 8 条

[1] Use of Intravenous Zanamivir after Development of Oseltamivir Resistance in a Critically Ill Immunosuppressed Child Infected with 2009 Pandemic Influenza A (H1N1) Virus [J].

Dulek, Daniel E. ;

Williams, John V. ;

Creech, C. Buddy ;

Schulert, Alynna K. ;

Frangoul, Haydar A. ;

Domm, Jennifer ;

Denison, Mark R. ;

Chappell, James D. .

CLINICAL INFECTIOUS DISEASES, 2010, 50 (11) :1493-1496

[2] Evaluation of the Antiviral Response to Zanamivir Administered Intravenously for Treatment of Critically Ill Patients With Pandemic Influenza A (H1N1) Infection [J].

Fraaij, P. L. A. ;

van der Vries, E. ;

Beersma, M. F. C. ;

Riezebos-Brilman, A. ;

Niesters, H. G. M. ;

van der Eijk, A. A. ;

de Jong, M. D. ;

Miranda, D. Reis ;

Horrevorts, A. M. ;

Ridwan, B. U. ;

Wolfhagen, M. J. H. M. ;

Houmes, R. J. ;

van Dissel, J. T. ;

Fouchier, R. A. M. ;

Kroes, A. C. M. ;

Koopmans, M. P. ;

Osterhaus, A. D. M. E. ;

Boucher, C. A. B. .

JOURNAL OF INFECTIOUS DISEASES, 2011, 204 (05) :777-782

[3] Intravenous Zanamivir for Oseltamivir-Resistant 2009 H1N1 Influenza [J].

Gaur, Aditya H. ;

Bagga, Bindiya ;

Barman, Subrata ;

Hayden, Randall ;

Lamptey, Aubrey ;

Hoffman, James M. ;

Bhojwani, Deepa ;

Flynn, Patricia M. ;

Tuomanen, Elaine ;

Webby, Richard .

NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (01) :88-89

[4] Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives [J].

Hurt, Aeron C. ;

Chotpitayasunondh, Tawee ;

Cox, Nancy J. ;

Daniels, Rod ;

Fry, Alicia M. ;

Gubareva, Larisa V. ;

Hayden, Frederick G. ;

Hui, David S. ;

Hungnes, Olav ;

Lackenby, Angie ;

Lim, Wilina ;

Meijer, Adam ;

Penn, Charles ;

Tashiro, Masato ;

Uyeki, Timothy M. ;

Zambon, Maria .

LANCET INFECTIOUS DISEASES, 2012, 12 (03) :240-248

[5] Community Transmission of Oseltamivir-Resistant A(H1N1)pdm09 Influenza [J].

Hurt, Aeron C. ;

Hardie, Kate ;

Wilson, Noelene J. ;

Deng, Yi-Mo ;

Osbourn, Maggi ;

Gehrig, Nicole ;

Kelso, Anne .

NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (26) :2541-2542

[6] H1N1 pneumonitis treated with intravenous zanamivir [J].

Kidd, I. Michael ;

Down, Jim ;

Nastouli, Eleni ;

Shulman, Rob ;

Grant, Paul R. ;

Howell, David C. J. ;

Singer, Mervyn .

LANCET, 2009, 374 (9694) :1036-1036

[7]

Wijaya L, 2011, SINGAP MED J, V52, P481

[8]

YATES PJ, 2010, OPT CONTR INFL 7 HON

← 1 →